Dr Reddys Laboratories shares witnessed a dip of nearly 1% after Mayo Clinic and Lifepoint Corporation include company’s name among defendant in a complaint filed in US District Court.
Mayo Clinic filed a complaint, invoking federal and state antitrust laws, along with other state laws. The complaint accused the defendants of restraining competition and establishing a shared monopoly in the sale of brand and generic Revlimid, citing their settlements in patent litigation as improper actions contributing to these practices.
